Alex Durso

Executive Director, Global Clinical Compliance at Novavax

Alex Durso, MBA has extensive work experience in biotechnology and pharmaceutical companies. Durso most recently held the position of Executive Vice President, Quality at ILiAD Biotechnologies, LLC since July 2023. Prior to that, Durso worked at NOVAVAX INC, where they had various roles including Executive Director, Global Clinical Compliance, Vice President, Global Clinical Compliance, and Sr. Director, Clinical Compliance. Before joining NOVAVAX INC, Durso worked at Takeda, where they held multiple senior director positions in quality management and operational excellence. Durso also has experience as a Principal/Consultant at Compass Consulting Solutions and held positions at Vertex Pharmaceuticals, Millennium Pharmaceuticals, PHT Corporation, Boehringer Ingelheim, and Genzyme Corporation.

Alex Durso, MBA, completed a Master of Business Administration degree from Curry College from 2012 to 2014. Prior to that, they obtained a Bachelor of Fine Arts degree in Visual Design, Photography, and Typography from the University of Massachusetts Dartmouth between 1989 and 1993.

Links

Previous companies

Novavax logo
Sanofi logo
Takeda Oncology logo
Vertex Pharmaceuticals logo
Boehringer Ingelheim logo
Takeda Pharmaceutical logo

Timeline

  • Executive Director, Global Clinical Compliance

    January, 2022 - present

  • Vice President, Global Clinical Compliance

    February, 2023

  • Sr. Director, Clinical Compliance

    April, 2021

View in org chart